Dr Balram Bhargava

Director General of Indian Council of Medical Research (ICMR) Dr Balram Bhargava on Thursday hailed the 96 per cent nationwide COVID-19 vaccination coverage of the first dose and said that India is heading towards becoming a vaccine super-power.

Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.

An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.

The new coronavirus variant, Omicron, is the predominant circulating strain in India, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said on Wednesday.

All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursday.

The majority of deaths in Mathura, Agra and Firozabad districts of Uttar Pradesh were due to dengue fever caused by D2 strain and it can cause haemorrhaging that could be fatal, ICMR Director-General Dr Balram Bhargava said on Thursday.

Lockdowns imposed by state governments to break the chain of transmission have to be lifted "very gradually, very slowly" to avoid a third wave of infections, ICMR chief Dr Balram Bhargava said Tuesday afternoon

One crore Covid vaccines will be available every day by mid-July, or early-August, ICMR chief Dr Balram Bhargava said Tuesday afternoon, as the centre doubled down on its aim of vaccinating the whole country - around 108 crore people - by end-2021.

There is no significant shift in the age distribution of COVID-19 cases in the second wave as compared to the first one, said Dr VK Paul, Member (Health) of the NITI Aayog, on Monday.

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.

A vaccine should first be given to adults, starting with teachers, to prevent community spread of the coronavirus disease through students, the chief of the Indian Council of Medical Research (ICMR) said responding to a query on when can Indians expect schools to reopen.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

There is a possibility of re-infection, if antibodies reduce in the body of a Covid-19 recovered person in five months time after the recovery, the Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said on Tuesday.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

ICMR chief Dr Balram Bhargava said has said that it is difficult to predict whether or not India will see a second wave of COVID-19 infections and there will be smaller peaks at different times due to varied geography of the country.

Director General of Indian Council of Medical Research (ICMR) Dr Balram Bhargava on Thursday hailed the 96 per cent nationwide COVID-19 vaccination coverage of the first dose and said that India is heading towards becoming a vaccine super-power.

Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.

An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.

The new coronavirus variant, Omicron, is the predominant circulating strain in India, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said on Wednesday.

All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursday.

The majority of deaths in Mathura, Agra and Firozabad districts of Uttar Pradesh were due to dengue fever caused by D2 strain and it can cause haemorrhaging that could be fatal, ICMR Director-General Dr Balram Bhargava said on Thursday.

Lockdowns imposed by state governments to break the chain of transmission have to be lifted "very gradually, very slowly" to avoid a third wave of infections, ICMR chief Dr Balram Bhargava said Tuesday afternoon

One crore Covid vaccines will be available every day by mid-July, or early-August, ICMR chief Dr Balram Bhargava said Tuesday afternoon, as the centre doubled down on its aim of vaccinating the whole country - around 108 crore people - by end-2021.

There is no significant shift in the age distribution of COVID-19 cases in the second wave as compared to the first one, said Dr VK Paul, Member (Health) of the NITI Aayog, on Monday.

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.

A vaccine should first be given to adults, starting with teachers, to prevent community spread of the coronavirus disease through students, the chief of the Indian Council of Medical Research (ICMR) said responding to a query on when can Indians expect schools to reopen.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

There is a possibility of re-infection, if antibodies reduce in the body of a Covid-19 recovered person in five months time after the recovery, the Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said on Tuesday.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

ICMR chief Dr Balram Bhargava said has said that it is difficult to predict whether or not India will see a second wave of COVID-19 infections and there will be smaller peaks at different times due to varied geography of the country.